publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
corvin
aj
et
al
endogen
inflammatori
respons
dermal
wound
heal
fetal
adult
mous
dev
dyn
olutoy
oo
et
al
lower
cytokin
releas
fetal
porcin
platelet
possibl
explan
reduc
inflamm
fetal
wound
j
pediatr
surg
olutoy
oo
et
al
hyaluron
acid
inhibit
fetal
platelet
function
implic
scarless
heal
paul
ehrlich
report
first
evid
immun
could
transmit
breastfeed
experiment
anim
organ
studi
possibl
human
report
howev
woodburi
grule
colleagu
separ
studi
found
incid
sever
diarrheal
diseas
much
lower
breastf
cow
milkf
infantsthos
observ
confirm
repeatedli
develop
industri
countri
furthermor
found
specif
protect
provid
breastfeed
encompass
bacteri
viral
enter
infect
due
pathogen
shigella
speci
salmonella
speci
escherichia
coli
vibrio
cholera
rotaviru
polioviru
follow
explan
protect
provid
breastfeed
advanc
human
milk
less
contamin
pathogen
microorgan
formula
feed
fewer
infect
would
transmit
breastf
infant
increas
space
birth
lactat
women
due
contracept
effect
lactat
densiti
children
suscept
common
contagi
agent
would
lower
famili
breastfeed
practic
addit
infant
breastf
would
less
like
groupcar
facil
thu
would
less
expos
children
harbor
microbi
pathogen
proposit
reason
complet
explain
protect
provid
breastfeed
respect
wyatt
mata
guatemala
found
manifest
infect
breastf
infant
low
even
bacteri
enteropathogen
shigella
recov
nippl
areola
breast
mother
furthermor
evid
emerg
breastf
infant
may
resist
certain
common
respiratori
infect
despit
earlier
studi
concept
characterist
mani
compon
immun
system
human
milk
reveal
last
half
centuri
follow
gener
featur
antimicrobi
agent
immun
system
human
milk
evid
certain
postnat
development
delay
immun
system
replac
agent
human
milk
postnat
delay
immun
system
offset
dissimilar
agent
human
milk
agent
human
milk
initi
augment
function
otherwis
poorli
express
infant
agent
human
milk
alter
physiolog
biochem
state
alimentari
tract
one
suit
fetal
life
one
appropri
extrauterin
life
defens
agent
human
milk
protect
without
provok
inflamm
agent
human
milk
inhibit
inflamm
defens
agent
human
milk
enhanc
surviv
gastrointestin
tract
recipi
infant
growth
factor
human
milk
augment
prolifer
commens
enter
bacteri
flora
realiz
mani
evolutionari
outcom
came
consequ
discoveri
expand
immun
system
human
milk
consist
antimicrobi
agent
also
antiinflammatori
immunomodul
agent
natur
function
agent
describ
follow
section
chapter
physic
featur
function
quantiti
antimicrobi
agent
human
milk
summar
tabl
discuss
follow
section
princip
protein
human
milk
antimicrobi
secretori
immunoglobulin
iga
antibodi
immunoglobulin
lactoferrin
lysozym
mucin
lactadhedrinthes
protein
except
immunoglobulin
secretori
iga
better
repres
human
milk
mammalian
milk
use
human
infant
nutrit
concentr
igm
much
lower
human
milk
serum
igm
molecul
blood
milk
pentam
howev
unlik
serum
igm
human
milk
igm
complex
immunolog
human
milk
host
immun
secretori
compon
antibodi
specif
human
milk
igm
may
similar
secretori
iga
human
milk
see
later
discuss
igg
also
present
human
milk
albeit
modest
amount
igg
subclass
repres
human
milk
rel
proport
higher
human
milk
serum
littl
igd
present
human
milk
ige
immunoglobulin
respons
immedi
hypersensit
reaction
essenti
absent
human
milk
secretori
iga
compris
immunoglobulin
human
milk
type
iga
consist
two
ident
iga
monom
unit
polypeptid
call
join
chain
complex
glycopeptid
secretori
compon
secretori
iga
assembl
dimer
iga
produc
plasma
cell
stroma
mammari
gland
bind
first
domain
polymer
immunoglobulin
receptor
basolater
surfac
epitheli
cell
investig
unusu
specif
antibodi
human
milk
spur
epidemiolog
evid
human
milk
protect
common
enter
respiratori
infecti
pathogen
discoveri
secretori
iga
human
milk
lar
hanson
led
studi
origin
b
cell
respons
product
immunoglobulin
part
antibodi
mechan
assembl
final
molecul
secretori
iga
specif
mani
antibodi
found
due
immunogentrigg
event
intestin
tract
later
ascertain
antigenstimul
b
cell
peyer
patch
lower
small
intestin
tract
migrat
mammari
gland
process
hormon
control
addit
bcell
pathway
lymphoid
tissu
bronchi
mammari
gland
discov
process
may
control
mucos
adhesioncel
adhes
system
eg
mucos
addressin
cell
adhes
molecul
madcam
counterstructur
integrin
certain
cytokin
mucos
antigen
stimul
cytokin
releas
mononuclear
cell
peyer
patch
induc
local
b
cell
switch
igm
iga
isotypeswitch
b
cell
migrat
sequenti
local
intestin
lymphat
channel
lymph
node
thorac
duct
vascular
circul
lactogen
hormon
influenc
poorli
understood
cell
move
vascular
compart
lactat
mammari
gland
iga
b
cell
differenti
iga
producingsecret
plasma
cell
remain
lamina
propria
mammari
gland
keep
mucos
lymphoid
tissu
iga
dimer
produc
plasma
cell
mammari
gland
princip
contain
chain
wherea
chain
predomin
immunoglobulin
human
sera
iga
dimer
produc
plasma
cell
bind
polymer
immunoglobulin
receptor
basolater
extern
membran
mammari
gland
epitheli
cell
result
receptordimer
iga
complex
transport
apic
side
entameoba
histolytica
cell
origin
intracytoplasm
portion
receptor
cleav
away
remain
molecul
secretori
iga
secret
milk
thu
enteromammari
bronchomammari
pathway
protect
immunolog
immatur
infant
pathogen
environ
dyad
tabl
import
given
secretori
iga
antibodi
antigenbind
repertoir
immunoglobulin
molecul
optim
produc
earli
infanc
furthermor
secretori
iga
molecul
human
milk
antiidiotyp
antibodi
therefor
may
oper
immun
agent
quantiti
secretori
iga
declin
lactat
proce
consider
amount
secretori
iga
transmit
recipi
infant
throughout
breastfeed
concentr
secretori
iga
human
milk
highest
colostrum
gradual
declin
plateau
mgml
approxim
mean
intak
secretori
iga
per
day
healthi
fullterm
breastf
infant
approxim
mgkg
per
day
month
approxim
mgkg
per
day
month
secretori
iga
resist
intestin
proteas
pancreat
trypsin
although
first
iga
subclass
suscept
bacteri
proteas
attack
hing
region
molecul
second
subclass
resist
proteas
disproport
increas
human
milk
furthermor
secretori
iga
antibodi
bacteri
iga
proteas
found
human
milk
keep
observ
amount
secretori
iga
excret
stool
low
birth
weight
infant
fed
human
milk
time
infant
fed
cow
milk
formula
addit
urinari
excret
secretori
iga
antibodi
recipi
increas
result
human
milk
feed
origin
secretori
iga
antibodi
urin
infant
fed
human
milk
undetermin
improb
human
milk
known
mechan
transport
entir
molecul
gastrointestin
tract
blood
blood
urin
lactoferrin
singlechain
glycoprotein
two
globular
lobe
display
site
bind
ferric
iron
lactoferrin
human
milk
ironbind
site
avail
compet
siderophil
bacteria
fungal
enterochelin
ferric
iron
chelat
iron
disrupt
prolifer
microbi
pathogen
addit
chelat
enhanc
bicarbon
princip
buffer
human
milk
lactoferrin
also
kill
bacteria
fungi
respons
part
molecul
lactoferricin
act
damag
outer
membran
pathogen
action
depend
ca
mg
fe
abil
chelat
fe
also
evid
lactoferrin
inhibit
certain
virus
manner
independ
iron
chelat
mean
concentr
lactoferrin
human
colostrum
mgml
volum
milk
product
increas
concentr
fall
mgml
month
lactat
mean
intak
milk
lactoferrin
healthi
breastf
fullterm
infant
mgkg
per
day
month
mgkg
per
day
month
resist
lactoferrin
proteolysi
excret
lactoferrin
stool
higher
infant
fed
human
milk
fed
cow
milk
formula
quantiti
lactoferrin
excret
stool
low
birth
weight
infant
fed
human
milk
prepar
approxim
time
excret
infant
fed
cow
milk
formula
estim
howev
may
high
presenc
immunoreact
fragment
lactoferrin
stool
human
milkf
infant
also
signific
increment
urinari
excret
intact
fragment
lactoferrin
result
human
milk
feed
stabl
isotop
studi
suggest
increment
urinari
lactoferrin
fragment
origin
ingest
human
milk
lactoferrin
lysozym
singl
chain
protein
lyse
suscept
bacteria
hydrolyz
linkag
nacetylmuram
acid
residu
cell
wall
high
concentr
lysozym
present
human
milk
stage
lactat
longitudin
chang
quantiti
lysozym
lactat
unlik
immun
factor
human
milk
mean
concentr
lysozym
colostrum
month
month
lactat
approxim
mean
daili
intak
milk
lysozym
healthi
fullterm
complet
breastf
infant
mgkg
per
day
month
mgkg
per
day
month
age
high
content
lysozym
human
milk
vitro
resist
proteolysi
keep
eightfold
increas
amount
lysozym
excret
stool
low
birth
weight
infant
fed
human
milk
compar
find
infant
fed
cow
milk
formula
howev
contrast
secretori
iga
lactoferrin
urinari
excret
protein
increas
infant
fed
human
milk
lysozym
c
gene
gave
rise
million
year
ago
gene
code
protein
express
lactat
mammari
glandth
protein
compon
lactos
synthetas
interest
three
domain
evolutionari
descend
lysozym
antibacteri
furthermor
multimer
may
antineoplast
fibronectin
high
molecular
weight
protein
facilit
uptak
mani
type
particul
mononuclear
phagocyt
present
human
milk
mean
concentr
colostrum
vivo
effect
broadspectrum
opsonin
human
milk
known
compon
classic
altern
pathway
complement
human
milk
concentr
compon
except
low
milk
mucin
high
molecular
weight
protein
greatli
glycosyl
twothird
mucin
human
milk
membran
boundth
concentr
mucin
human
milk
mgml
number
milk
mucin
identifiedth
promin
one
molecular
weight
kda
primarili
bound
membran
milk
fat
globul
respect
human
milk
fat
globul
mucin
membran
inhibit
bind
sfimbriat
e
coli
human
epitheli
cell
vivo
fate
ingest
investig
found
resist
intragastr
digest
preterm
infant
major
fragment
detect
fece
breastf
infant
furthermor
mucin
fece
abl
inhibit
bacteri
adhes
fece
formulaf
infant
origin
report
human
milk
mucin
defend
rotaviru
common
caus
infecti
enter
human
infant
experiment
murin
model
rotaviru
bound
milkmucin
complex
also
compon
complex
activ
compon
later
found
separ
glycoprotein
design
lactadherin
like
human
lactadhedrin
resist
intragastr
digest
oligosaccharid
human
milk
produc
glycosyltransferas
mammari
gland
abund
compound
receptor
analogu
inhibit
bind
certain
enter
respiratori
bacteri
pathogen
toxin
epitheli
cell
mani
type
oligosaccharid
identifi
human
milk
new
type
still
recogn
oligosaccharid
human
milk
differ
found
commerci
milk
formula
although
quantiti
total
gangliosid
human
bovin
milk
similar
rel
frequenc
type
gangliosid
milk
two
speci
distinct
exampl
much
monosialogangliosid
gm
found
human
bovin
milk
chemistri
compound
dictat
specif
bind
adher
structur
bacteri
pathogen
exampl
gm
gangliosid
receptor
analogu
toxin
produc
v
cholera
e
coli
wherea
globotriaosylceramid
bind
subunit
shigatoxin
fucosyloligosaccharid
inhibit
stabl
toxin
e
coli
wherea
differ
one
inhibit
campylobact
jejuni
oligosaccharid
human
milk
also
interfer
attach
haemophilu
influenza
streptococcu
pneumonia
regard
galdisaccharid
subunit
block
attach
pneumonia
respiratori
epithelium
vivo
anim
experi
also
suggest
oligosaccharid
glycoconjug
human
milk
protect
certain
enter
bacteri
infect
regard
certain
human
milk
oligosaccharid
surviv
passag
alimentari
tract
absorb
carbohydr
excret
urinari
tract
sugar
present
sever
glycoconjug
includ
mucin
lactadherin
secretori
iga
also
interfer
bind
bacteri
pathogen
epitheli
cell
addit
direct
antibacteri
effect
carbohydr
human
milk
nitrogencontain
oligosaccharid
glycoprotein
glycopeptid
human
milk
growth
promot
lactobacilli
bifidobacilli
exampl
growthpromot
activ
associ
casein
may
resid
oligosaccharid
moieti
complex
molecul
factor
respons
great
extent
predomin
lactobacilli
bifidobacilli
bacteri
flora
larg
intestin
breastf
infant
found
studi
bacteria
produc
larg
amount
acet
acid
aid
suppress
multipl
enteropathogen
also
report
lactobacilli
strain
gg
aid
recoveri
acut
rotaviru
infect
may
enhanc
format
specif
igg
iga
igm
antibodi
addit
enter
commens
bacteria
may
stimul
product
low
molecular
weight
antibacteri
peptid
defensin
type
defens
mechan
may
contribut
compar
immunolog
human
milk
host
immun
pauciti
stool
breastf
infant
bacteri
pathogen
often
found
urinari
tract
infect
pfimbriat
e
coli
fatti
acid
monoglycerid
gener
enzymat
digest
lipid
substrat
human
milk
disrupt
envelop
virus
antivir
lipid
may
aid
prevent
coronaviru
infect
intestin
tract
defend
intestin
parasit
giardia
lamblia
entameoba
histolytica
monoglycerid
milk
lipid
hydrolysi
also
inactiv
certain
gramposit
gramneg
bacteria
vivo
hydrolysi
ingest
milk
lipid
earli
infanc
occur
two
enzymat
mechanismsth
first
due
action
lingual
lipas
second
due
activ
human
milk
bilesalt
stimul
lipas
duodenum
thu
like
product
lipid
digest
contribut
defens
breastf
infant
enter
infect
live
leukocyt
found
human
milk
contrast
b
cell
transform
plasma
cell
remain
sessil
mammari
gland
leukocyt
attract
site
travers
mammari
epithelium
becom
part
milk
secret
highest
concentr
leukocyt
human
milk
occur
first
day
lactat
ml
sever
type
leukocyt
major
featur
follow
rel
frequenc
cell
b
cell
among
lymphocyt
earli
human
milk
secret
respect
small
number
natur
killer
nk
cell
human
milk
keep
low
cytotox
activ
human
milk
leukocyt
small
number
b
cell
reflect
b
cell
enter
lamina
propria
mammari
gland
transform
sessil
plasma
cell
helper
cytotoxicsuppressor
tcell
subpopul
present
human
milk
compar
human
blood
cell
proport
cytotoxicsuppressor
cell
human
milk
increas
virtual
cell
human
milk
bear
isoform
indic
cellular
activ
addit
increas
proport
cell
display
phenotyp
marker
activ
cell
human
milk
produc
certain
cytokin
macrophag
migrat
inhibitori
factor
monocyt
chemotact
factor
product
consist
phenotyp
cell
human
milk
find
cell
major
sourc
cytokin
addit
cytokin
produc
human
milk
leukocyt
extent
product
secret
determin
neutrophil
macrophag
human
milk
laden
milk
fat
globul
perhap
membran
phagocyt
intracytoplasm
bodi
cell
difficult
identifi
common
stain
methodsthey
identifi
howev
content
myeloperoxidas
case
neutrophil
nonspecif
esteras
case
macrophag
surfac
express
case
macrophag
type
cell
human
milk
phagocyticther
evid
respiratori
burst
occur
milk
macrophag
stimul
intracellular
kill
activ
appear
reducedth
macrophag
also
found
process
present
antigen
cell
exposur
chemoattract
human
milk
neutrophil
compar
blood
neutrophil
increas
adher
polar
direct
migrat
deform
featur
appear
due
agent
human
milk
exampl
decreas
calcium
influx
human
milk
neutrophil
duplic
incub
blood
neutrophil
human
milk
unlik
human
milk
neutrophil
motil
macrophag
human
milk
increas
compar
counterpart
blood
featur
neutrophil
macrophag
human
milk
appear
due
cellular
activ
cell
display
phenotyp
marker
activ
includ
increas
express
decreas
express
lselectin
vivo
fate
role
human
milk
leukocyt
defens
infant
well
understoodth
area
upper
alimentari
respiratori
tract
seem
provid
potenti
site
human
milk
leukocyt
enter
consider
interest
small
number
memori
cell
detect
blood
infanc
thu
may
possibl
matern
memori
cell
milk
compens
development
delay
product
infant
evid
experiment
anim
studi
milk
lymphocyt
enter
tissu
neonat
demonstr
humansther
also
report
transfer
cellular
immun
breastfeed
import
ascertain
whether
report
verifi
test
cellular
immun
mani
differ
antigen
young
infant
breastf
inflammatori
agent
system
give
rise
poorli
repres
human
milk
includ
coagul
system
kallikreinkininogen
system
major
compon
complement
system
ige
basophil
mast
cell
eosinophil
cytotox
lymphocyt
certain
proinflammatori
cytokin
see
subsequ
discuss
found
human
milk
clinic
evid
gener
inflammatori
process
recipi
contrast
pauciti
inflammatori
agent
human
milk
contain
host
antiinflammatori
agent
includ
factor
promot
growth
epithelium
thu
strengthen
mucos
barrier
antioxid
agent
lactoferrin
interfer
certain
complement
compon
enzym
degrad
mediat
inflamm
proteas
inhibitor
agent
bind
substrat
lysozym
elastin
cytoprotect
agent
prostaglandin
e
e
f
agent
inhibit
function
inflammatori
leukocyt
tabl
like
antimicrobi
factor
mani
factor
adapt
oper
hostil
environ
alimentari
tract
main
antioxid
human
milk
includ
ascorbatelik
compound
uric
acid
fact
blood
level
higher
breastf
formulaf
infant
supplement
agent
mucos
growth
factor
human
milk
includ
epitheli
growth
factor
lactoferrin
cortisol
polyamin
hormon
growth
factor
human
milk
may
also
affect
growth
differenti
turnov
epitheli
cell
agent
may
therefor
limit
penetr
free
antigen
pathogen
microorgan
affect
barrier
function
intestin
tract
keep
notion
signific
differ
biophys
biochem
organ
function
mucos
barrier
adult
xx
development
immunobiolog
neonat
furthermor
matur
function
may
acceler
human
milk
enzym
human
milk
degrad
inflammatori
mediat
may
damag
gastrointestin
tract
respect
plateletactiv
factor
paf
play
role
intestin
injuri
rat
induc
endotoxin
hypoxia
furthermor
acetylhydrolas
degrad
paf
present
human
milk
product
human
pafacetylhydrolas
development
delay
publish
result
investig
also
indic
human
milk
feed
lessen
intestin
permeabl
young
infant
three
set
observ
provid
basi
concept
immunomodul
agent
human
milk
epidemiolog
investig
suggest
older
children
breastf
infanc
may
less
risk
develop
certain
chronic
diseas
mediat
immunolog
inflammatori
oncogen
mechanismsth
diseas
question
type
diabet
mellitu
lymphoma
acut
lymphocyt
leukemia
crohn
diseas
although
prevent
lessen
infect
antimicrobi
agent
antiinflammatori
agent
human
milk
may
longterm
consequ
agent
influenc
develop
system
mucos
defens
infant
may
also
respons
possibl
longterm
effect
infant
account
passiv
transfer
substanc
human
milk
breastfeed
prime
recipi
produc
higher
blood
level
respons
respiratori
syncyti
viru
infect
addit
increment
blood
level
fibronectin
achiev
breastfeed
account
amount
protein
human
milk
moreov
breastfeed
lead
rapid
develop
system
secretori
antibodi
respons
secretori
iga
extern
secret
includ
urin
far
remov
rout
ingest
therefor
increment
due
absorpt
factor
human
milk
third
line
evid
discoveri
leukocyt
human
milk
activ
see
previou
section
leukocyt
investig
reveal
human
milk
enhanc
movement
blood
monocyt
vitro
addit
much
motil
abrog
antibodi
tumor
necrosi
subsequ
human
milk
detect
immunochem
mani
cytokin
found
human
milk
includ
cytokin
interleukin
il
proinflammatori
cytokin
includ
chemotaxin
includ
regul
activ
normal
express
secret
rant
eotaxin
antiinflammatori
agent
transform
growth
cellular
growth
factor
egf
granulocyt
colonystimul
factor
gcsf
macrophagecsf
hepat
growth
factor
erythropoietin
tabl
controversi
concern
quantiti
agent
human
milk
discrep
result
studi
may
depend
differ
storag
condit
specimen
type
immunoassay
site
extent
effect
recipi
infant
determin
sever
immunomodul
agent
human
milk
includ
prolactin
antiidiotyp
antibodi
host
nucleotid
enhanc
nkcell
macrophag
activ
previous
mention
seven
somewhat
overlap
evolutionari
outcom
concern
relationship
immun
statu
infant
defens
agent
human
milk
recogn
respect
first
evolutionari
outcom
mani
aspect
human
immun
system
incomplet
develop
birth
immatur
mark
low
birth
weight
infant
development
delay
includ
mobil
function
neutrophil
product
lysozym
secretori
iga
mucos
site
memori
cell
bear
complet
express
antibodi
repertoir
product
certain
cytokin
includ
gcsf
gmcsf
mani
development
delay
defens
factor
well
repres
human
milk
tabl
exampl
secretori
iga
antibodi
human
milk
compens
low
product
secretori
iga
mucos
site
earli
infanc
also
import
antibodi
respons
achiev
pathway
polyclon
direct
protein
also
polysaccharid
antigen
infant
display
restrict
clonal
mount
igg
antibodi
respons
polysaccharid
antigen
problem
modifi
introduct
conjug
vaccin
even
immunolog
human
milk
host
immun
antibodi
respons
conjug
vaccin
higher
breastf
cow
milkf
infant
addit
exampl
interrelationship
amount
lysozym
produc
infant
quantiti
secret
milk
inde
necess
high
lysozym
level
human
milk
coupl
low
product
protein
mucos
cell
infanc
like
attain
normal
intralumin
concentr
lysozym
infanc
depend
breastfeedingthi
keep
find
higher
lysozym
activ
stool
breastf
nonbreastf
infant
potenti
vivo
effect
immun
factor
human
milk
recipi
infant
depend
surviv
agent
although
may
argu
defens
agent
human
milk
would
destroy
digest
process
gastrointestin
tract
mani
agent
may
bioactiv
alimentari
respiratori
tract
follow
reason
protein
compon
may
affect
epithelium
leukocyt
cell
proxim
part
alimentari
respiratori
tract
proteolyt
enzym
produc
ingest
protein
may
escap
intragastricintraduoden
digest
development
delay
product
gastric
hcl
pancreat
proteas
resist
digest
may
augment
protect
provid
buffer
capac
human
milk
shield
acidlabil
compon
milk
antiproteas
human
milk
inher
resist
mani
defens
agent
human
milk
digest
process
protect
digest
defens
agent
human
milk
compartment
respect
much
human
milk
bound
solubl
receptor
thesi
born
previous
discuss
increas
surviv
certain
human
milk
defens
agent
alimentari
tract
recipi
infant
matur
delay
immun
system
gener
profound
prematur
infant
furthermor
potenti
immunolog
problem
compound
shorten
durat
placent
transfer
igg
fetu
predispos
prematur
infant
certain
opportunist
infect
moreov
major
medic
problem
newborn
period
includ
pulmonari
diseas
nutrit
imbal
invas
clinic
procedur
increas
risk
prematur
infant
infect
thelper
cytokinemacrophag
activ
activ
cell
macrophag
enhanc
iga
product
chemotaxin
neutrophil
cell
cytokin
inhibit
product
mani
pro
inflammatori
cytokin
cytokin
enhanc
product
enhanc
product
polymer
ig
receptor
enhanc
isotyp
switch
iga
b
cell
gcsf
increas
granulocyt
neutrophil
product
mcsf
increas
monocyt
product
gcsf
granulocyt
coloni
stimul
factor
mcsf
monocyt
coloni
stimul
factor
transform
growth
tumor
necrosi
pafah
platelet
activ
factoracetylhydrolas
tumor
necrosi
milk
women
deliv
prematur
contain
mani
antimicrobi
factor
found
milk
women
deliv
fullterm
pregnanc
includ
secretori
iga
lactoferrin
lysozymeth
concentr
defens
agent
higher
preterm
term
milkthos
higher
concentr
may
larg
part
due
lower
volum
milk
produc
women
deliv
prematurelythat
may
total
explan
higher
concentr
pattern
concentr
antimicrobi
factor
preterm
term
milk
exactli
moreov
concentr
antiinflammatori
immunomodul
factor
preterm
milk
establish
addit
protect
enter
infect
respiratori
infect
otiti
media
sever
indic
human
milk
feed
protect
prematur
infant
system
infect
prone
occur
immatur
infant
winberg
colleagu
sweden
report
risk
bacteri
sepsi
less
prematur
newborn
infant
fed
human
milk
observ
confirm
yu
cowork
australia
nayaryanan
associ
india
found
supplement
feed
express
human
milk
associ
reduc
frequenc
infect
low
birth
weight
infant
human
milk
also
protect
mani
case
necrot
enterocol
nec
factor
human
milk
respons
protect
remain
elucid
evid
human
experiment
anim
studi
suggest
iga
erythropoietin
pafacetylhydrolas
like
possibl
case
development
delay
product
suspect
factor
agent
question
wellrepres
human
milk
two
contrast
experiment
anim
model
cytokin
gene
defici
suggest
antiinflammatori
cytokin
human
milk
may
prevent
disord
due
inflammatori
process
mice
homozyg
null
gene
display
spontan
infiltr
macrophag
cell
mani
organ
site
lung
heart
salivari
gland
promin
involv
furthermor
experiment
evid
effect
defici
mitig
ingest
cytokin
murin
milk
second
anim
model
target
gene
delet
engin
mice
anim
fatal
enterocol
began
directli
wean
depend
establish
enter
bacteri
flora
enterocol
featur
crohn
diseas
nec
much
enterocol
anim
prevent
intraperiton
inject
given
start
wean
although
establish
whether
human
milk
feed
protect
pulmonari
vascular
effect
hyperoxia
experiment
evid
suggest
one
antiinflammatori
compon
human
milk
antitrypsin
prevent
mani
featur
hyperox
neonat
rat
includ
elev
pulmonari
elastolyt
activ
possibl
effect
human
milk
upon
develop
atop
diseas
investig
mani
group
consensu
whether
breastfeed
protect
disord
except
atop
dermat
food
allergen
avoid
complet
breastfeed
much
disagr
probabl
due
confound
variabl
includ
variat
genet
predisposit
atop
disord
suffici
breastfeed
dietari
exposur
appreci
parent
exposur
inhal
allergen
irrit
might
lead
lung
damag
furthermor
evid
increas
exposur
infecti
diseas
facilit
respons
lead
develop
cellular
immun
wherea
much
lower
exposur
engend
respons
lead
antibodi
format
henc
possibl
igemedi
hypersensitivitythu
effect
breastfeed
risk
atop
diseas
may
well
depend
multipl
factor
equal
repres
investig
popul
moreov
question
complic
transmiss
foreign
food
antigen
human
milk
trigger
allerg
reaction
antigen
recipi
infant
subpopul
breastf
infant
develop
atop
diseas
unknown
establish
whether
breastf
infant
react
foreign
food
antigen
human
milk
necessari
conduct
trial
dietari
elimin
oral
challeng
food
question
mother
breastfeed
trial
suggest
infant
react
foreign
food
antigen
human
milk
problem
may
avoid
elimin
food
allergen
matern
diet
food
allergen
basic
food
cow
milk
woman
must
diet
suppli
correct
type
quantiti
nutrient
meet
need
lactat
longterm
elimin
impract
breastfeed
may
stop
infant
tri
hypoallergen
formula
addit
develop
allerg
diseas
breastf
infant
may
due
alter
type
fatti
acid
found
milk
produc
mother
allerg
infant
influenc
human
milk
feed
upon
rate
rehospit
prematur
infant
examin
nation
matern
infant
health
survey
conduct
nation
institut
child
health
human
develop
although
causeeffect
relationship
could
definit
establish
feed
human
milk
independ
predictor
decreas
risk
rehospit
thu
human
milk
feed
may
benefici
effect
prematur
infant
extend
beyond
initi
hospit
human
milk
contain
array
host
resist
factor
antimicrobi
antiinflammatori
immunomodul
immun
system
adapt
function
mucos
site
protect
recipi
host
infecti
inflammatori
process
common
develop
infant
addit
may
longterm
health
benefit
recipi
human
milk
feed
appar
due
alter
immun
system
precis
way
immunolog
agent
human
milk
protect
child
agent
interact
develop
immun
system
recipi
well
understoodthes
research
issu
requir
coordin
effort
neonatologist
immunologist
molecular
biologist
clinic
basic
scientist
lung
uniqu
intern
organ
situat
within
bodi
yet
interpos
host
environ
develop
pulmonari
host
defens
mechan
capabl
restrict
growth
environment
pathogen
therefor
essenti
step
evolut
airbreath
anim
effect
ga
exchang
environ
lung
must
abl
buffer
potenti
injuri
effect
airway
alveoli
multipl
substanc
includ
pathogen
organ
may
present
air
stream
neonat
typic
minut
ventil
rang
ml
kg
min
requir
lung
filter
approxim
l
inhal
air
hourli
problemat
task
alveolar
surfac
area
requir
protect
time
averag
neonat
bodi
surfac
area
mechan
must
also
exist
prevent
contain
effect
potenti
pathogen
deliv
aspir
oropharyng
secret
concomitantli
lung
reticuloendotheli
structur
also
respons
filter
blood
return
left
atrium
via
pulmonari
circul
thu
extens
alveolarcapillari
membran
compos
immun
nonimmun
cell
may
encount
pathogen
hematogen
rout
well
inhal
beyond
signific
environment
exposur
host
defens
lung
present
uniqu
challeng
individu
alveoli
expos
environ
parallel
thu
must
somewhat
selfsuffici
initi
antigen
respons
furthermor
alveolarcapillari
interfac
teleolog
evolv
ga
exchang
offer
littl
barrier
pathogen
movement
either
direct
final
even
mild
inflamm
critic
locat
significantli
impair
ga
exchang
threaten
host
surviv
airway
lower
respiratori
tract
normal
contain
coloni
essenti
commens
organ
evolv
pulmonari
mechan
pathogen
contain
clearanc
immunolog
nonimmunolog
clearli
effect
avail
pulmonari
host
defens
broadli
categor
either
mechan
immunolog
exampl
mechan
defens
includ
larynx
epiglotti
anatom
situat
minim
aspir
oropharyng
materi
airway
angul
mucu
secret
mucociliari
clearanc
mechan
includ
cough
reflex
mechan
result
progress
filter
inhal
particl
pass
conduct
airway
overal
level
antigen
exposur
given
site
invers
relat
depth
within
respiratori
tree
mechan
barrier
compon
host
defens
thu
minim
bulk
exposur
pathogen
antigen
minim
frequenc
host
immun
respons
activ
avail
immunolog
mechan
recent
convent
broadli
categor
either
innat
adapt
innat
immun
respons
nonspecif
reli
host
recognit
pathogenassoci
molecular
pattern
peptidoglycan
endotoxin
fungal
mannan
foreign
pattern
recogn
ligat
either
solubl
bioactiv
substanc
within
airway
defensin
collectin
pattern
recognit
receptor
macrophag
subsequ
gener
earli
respons
cytokin
tumor
necrosi
factor
interleukin
il
chemotaxin
leukotrien
chemokin
split
compon
complement
lead
recruit
addit
cellular
element
innat
immun
granulocyt
natur
killer
cell
mean
concurr
cytokin
network
cell
alveolar
milieu
includ
epithelia
fibroblast
alveolar
macrophag
activ
antigenpres
cell
lymphocyt
move
alveolar
compart
recruit
special
lymphocyt
cell
b
cell
herald
onset
adapt
immun
respons
cell
manifest
specif
receptor
somat
gener
respons
specif
antigen
facilit
immunolog
memori
longterm
cellmedi
humor
immun
adapt
immun
thu
initi
target
respons
aim
contain
clearanc
specif
antigen
allow
titrat
nonspecif
potenti
host
injuri
alveolar
inflamm
anatom
locat
element
pulmonari
innat
immun
respons
typic
preced
adapt
immun
howev
complex
